The company added that former Bristol Myers Squibb CEO Giovanni Caforio would be proposed as Chair of the Board of Directors at the 2025 annual shareholders meeting as incumbent Joerg Reinhardt will not run again after 12 years in office.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/057hJdj
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment